Rheumatology & Arthritis Learning Network

Shikha Singla, MD, on Comparative Analysis of Guidelines for Psoriatic Arthritis by Rheumatology & Arthritis Learning Network

Philip Mease, MD, on the POETYK Trials of Deucravacitinib in PsA: Part 2 by Rheumatology & Arthritis Learning Network

Philip Mease, MD, on the POETYK Trials of Deucravacitinib in Psoriatic Arthritis. by Rheumatology & Arthritis Learning Network

Dacre Knight, MD, on Hypermobility Syndromes by Rheumatology & Arthritis Learning Network

Leonard Calabrese, DO, on Long COVID by Rheumatology & Arthritis Learning Network

Misti Paudel, PhD, on Difficult-to-Treat Rheumatoid Arthritis by Rheumatology & Arthritis Learning Network

Vikas Majithia, MD, and Ronald Butendieck, MD, on the Continuing Challenges of Gout by Rheumatology & Arthritis Learning Network

Risk Factors for COVID-19 Reinfection Among Patients With Rheumatic Diseases by Rheumatology & Arthritis Learning Network

Dr Birnbaum comments on how the new rule from the Centers for Medicare & Medicaid Services setting tighter timelines for health insurers to act on requests for authorization for medications and procedures.

Dr Leonard Calabrese of the Cleveland Clinic discusses the similarities and differences of fibromyalgia, chronic fatigue syndrome, and long COVID, and why classifying these diseases properly is important to diagnosis and treatment.

Dr Myasoedova, from Mayo Clinic in Rochester, Minnesota, reviews recent research showing that extra-articular manifestations of rheumatoid arthritis are on the decline.

Dr Fleischmann reviews a post hoc analysis of the SELECT phase 3 trial of upadacitinib in rheumatoid arthritis and the safety of JAK inhibitors among RA patients at risk for cardiovascular events.

Dr Baker discusses research indicating that patients with asthma or atopic dermatitis have a significantly higher risk of developing osteoarthritis over 10 years of follow-up.

Dr Patricia Katz sheds light on the cohort analysis findings that suggest a positive correlation between mental wellbeing—a common burden among patients with chronic inflammatory diseases—and COVID-19 vaccination. Patricia Katz, PhD, is a professor of medicine and health policy at the University of California San Francisco.

The risk of cardiovascular diseases among patients with rheumatoid arthritis goes beyond just heart attacks and strokes. Findings of a large cohort study revealed that patients with RA were at a higher risk of developing aortic stenosis—either by needing an aortic valve intervention or aortic stenosis-related death.

In this podcast, Dr Philip Mease reviews recent research on the importance of assessing treatment response across all domains of psoriatic arthritis, including skin, joints, entheses, and more.

Dr Ho So of the Chinese University of Hong Kong discussed his research into whether glucocorticoids — specifically prednisolone — for rheumatoid arthritis may increase the risk of major adverse cardiovascular events among these patients.

In a cross-sectional study of 36 isolated nail psoriasis patients, 7 of them (19%) went on to develop psoriatic arthritis in the following years. Is there more to this connection between isolated nail psoriasis and early detection of PsA? Dr Shari Lipner of Weill Cornell Medical Center explains.

Did you know orthopedics has the lowest percentage of women residents of all specialties? In this podcast, Dr Nicholas Bertha sheds light how gender inequality in orthopedic surgery is real and well-documented.

In this podcast, Drs Bryant England and Ben Smith, who served on the committee that developed the first ACR guideline on exercise, diet, and other aspects of integrative care for arthritis, discuss its major recommendations and approaches.

Dr Baker reviews the findings of his recent research into the association of interstitial lung disease among patients with rheumatoid arthritis who have been treated with both biologic and targeted disease-modifying antirheumatic drugs.

Dr Ogdie reviews her recent research into how men and women experience psoriatic arthritis, including its effects on quality of life and physical functioning.

Dr England gives us the key points from his study on whether certain multimorbidity patterns are associated with long-term disease severity among patients with rheumatoid arthritis.

More than 50% of patients with rheumatoid arthritis (RA) suffer from sleep fragmentation and obstructive sleep apnea, which effectively results in poor quality of sleep. Do patients with RA also suffer from restless leg syndrome? Is there any treatment or medication? Dr Patricia Katz explains.

Dr W. Benjamin Nowell, of the Global Healthy Living Foundation, discusses his abstract from EULAR 2023 on results of a patient survey on what blood tests reveal about rheumatoid arthritis activity and medications.